Ospina-Tascón, Gustavo A.
Teboul, Jean-Louis
Hernandez, Glenn
Alvarez, Ingrid
Sánchez-Ortiz, Alvaro I.
Calderón-Tapia, Luis E.
Manzano-Nunez, Ramiro
Quiñones, Edgardo
Madriñan-Navia, Humberto J.
Ruiz, Juan E.
Aldana, José L.
Bakker, Jan
Article History
Received: 6 January 2020
Accepted: 4 April 2020
First Online: 16 April 2020
Ethics approval and consent to participate
: The ethical and research committee involving human beings approved the current study (Protocol number 1238, IRB/EC approval number 099-2018, Fundación Valle del Lili, Cali, Colombia).The ANDROMEDA-SHOCK randomized clinical trial was conducted at 28 hospitals in 5 countries (Argentina, Chile, Colombia, Ecuador, Uruguay). The institutional review board at each site approved the study and the use of data for post hoc analysis.
: Not applicable.
: The authors declare that they have no competing interests.